B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

HRH2

MOLECULAR TARGET

histamine receptor H2

UniProt: P25021NCBI Gene: 327438 compounds

HRH2 (histamine receptor H2) is targeted by 38 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting HRH2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Histamine3.1823
2Cimetidine2.8917
3Pramipexole1.795
4Burimamide1.614
5Bromocriptine1.102
6Dihydroergotamine1.102
7Impromidine1.102
8Methysergide1.102
9Pergolide1.102
10Amlodipine0.691
11Fluoxetine0.691
12Mianserin0.691
13Quetiapine Fumarate0.691
14Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent0.691
15Amoxapine0.691
16Aripiprazole0.691
17Astemizole Antihistamine drug now withdrawn from0.691
18Betazole0.691
19Cabergoline0.691
20Carvedilol0.691
21Cetirizine0.691
22Chlorpheniramine0.691
23Clonidine0.691
24Crizotinib0.691
25Dexpramipexole0.691
26Dihydroergocornine0.691
27Famotidine0.691
28Hydroxyzine0.691
29Lisuride0.691
30Loratadine0.691
31Loxapine0.691
32Meclizine0.691
33Metergoline0.691
34Methylergonovine0.691
35Metiamide0.691
36Promethazine0.691
37Ranitidine0.691
38Somatostatin0.691

About HRH2 as a Drug Target

HRH2 (histamine receptor H2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 38 compounds with documented HRH2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

HRH2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.